Cipalat XR 30 mg, 60 mg XR tablets
PDF Leaflet Revision Date: 06 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension and prophylaxis of chronic stable angina pectoris.
Dosage (summary)
Adults: Initial 30 mg once daily, max 90 mg once daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Grapefruit juice
- Digoxin
- Phenytoin
- Rifampicin
Contraindications
- Hypersensitivity to nifedipine
- Aortic stenosis
- Cardiogenic shock
- Unstable angina
- Hepatic impairment
Common side effects
- Headache
- Oedema
- Constipation
- Dizziness
Counselling Points
- Swallow tablets whole
- Avoid grapefruit juice
- Monitor blood pressure regularly
Serious warnings
- Severe hypotension risk
- Deterioration of heart failure
- Grapefruit juice interaction
Important Disclaimer
The Cipalat XR 30 mg, 60 mg XR tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
